6
Clinical Trials associated with SJP-0008SJP-0008 Phase III Study -A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study in Participants with Central Retinal Artery Occlusion-
Start Date08 Feb 2024 |
Sponsor / Collaborator- |
SJP-0008 Phase I -Drug-Drug Interaction Study in Healthy Japanese Adult Subjects-
Start Date22 Nov 2021 |
Sponsor / Collaborator- |
A Single Dose Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]SJP-0008 in Healthy Male Subjects After an Oral Dose
This single centre, open-label, non-randomised, single period, single-dose study in healthy male subjects was designed and conducted to assess the mass balance recovery, PK, metabolite profile and metabolite identification of SJP-0008.
100 Clinical Results associated with SJP-0008
100 Translational Medicine associated with SJP-0008
100 Patents (Medical) associated with SJP-0008
100 Deals associated with SJP-0008